PDS BIOTECHNOLOGY CORP has a total of 72 patent applications. It decreased the IP activity by 35.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NATURE TECHNOLOGY INC, HOUGH EAR INST and SOUND PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | China | 10 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | WIPO (World Intellectual Property Organization) | 8 | |
#5 | Australia | 7 | |
#6 | Taiwan | 7 | |
#7 | Canada | 5 | |
#8 | Israel | 4 | |
#9 | Republic of Korea | 3 | |
#10 | Brazil | 2 | |
#11 | Japan | 2 | |
#12 | Mexico | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Bedu-Addo Frank | 58 |
#2 | Ward Martin | 26 |
#3 | Conn Greg | 26 |
#4 | Woodward Jerold | 26 |
#5 | Conn Gregory | 22 |
#6 | Johnson Kenya | 22 |
#7 | Jacobson Eric | 21 |
#8 | Huang Leaf | 17 |
#9 | Gandhapudi Siva K | 14 |
#10 | Chen Weihsu | 13 |
Publication | Filing date | Title |
---|---|---|
WO2019113200A1 | Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes | |
WO2018067822A1 | Methods to alter the tumor microenvironment for effective cancer immunotherapy | |
US2018094032A1 | Novel hpv16 non hla-restricted t-cell vaccines, compositions and methods of use thereof | |
AU2016354590A1 | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy | |
TW201427686A | Improved vaccine compositions and methods of use | |
CA2876656A1 | Cationic lipid vaccine compositions and methods of use | |
CN104066444A | Particluate vaccine formulations | |
EP2276495A1 | Stimulation of an immune response by enantiomers of cationic lipids | |
CN101702882A | Stimulation of an immune response by cationic lipids | |
US2006008472A1 | Antigen delivery compositions and methods of use |